FDA approves migraine pill as preventative treatment
![Photo: Manuel Balce Ceneta/AP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13017930.ece/ALTERNATES/schema-16_9/20345686002432-1920x1920we-go.jpg)
The preventative treatment industry for migraines has gained a new player in the form of US-based firm Biohaven, which can now start competing with companies like Lundbeck, Amgen and Eli Lilly following a recent FDA approval.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lundbeck backs Trintellix with new data
For subscribers